Life Technologies, Fluidigm Reach Licensing Deals, End Litigation | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluidigm and Life Technologies have reached cross-licensing and sub-licensing deals covering PCR-related technologies, imaging readers, and other technologies, putting an end to dual lawsuits the firms had filed against each other alleging patent infringement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.